119 related articles for article (PubMed ID: 11205276)
41. [Preparation of long-circulating nolatrexed dihydrochloride liposomes and its antitumor activity].
Chen SZ; Wang SM; Zhang JR
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):403-5. PubMed ID: 18359701
[TBL] [Abstract][Full Text] [Related]
42. Importance of the liposomal cationic lipid content and type in tumor vascular targeting: physicochemical characterization and in vitro studies using human primary and transformed endothelial cells.
Dabbas S; Kaushik RR; Dandamudi S; Kuesters GM; Campbell RB
Endothelium; 2008; 15(4):189-201. PubMed ID: 18663622
[TBL] [Abstract][Full Text] [Related]
43. Visualisation of liposomes prepared from skin and stratum corneum lipids by transmission electron microscopy.
Hatziantoniou S; Nezis IP; Margaritis LH; Demetzos C
Micron; 2007; 38(8):777-81. PubMed ID: 17681473
[TBL] [Abstract][Full Text] [Related]
44. Effect of various formulation variables on the encapsulation and stability of dibucaine base in multilamellar vesicles.
Nounou MM; El-Khordagui LK; Khalafallah N
Acta Pol Pharm; 2005; 62(5):369-79. PubMed ID: 16459486
[TBL] [Abstract][Full Text] [Related]
45. Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs.
Brignole C; Pastorino F; Marimpietri D; Pagnan G; Pistorio A; Allen TM; Pistoia V; Ponzoni M
J Natl Cancer Inst; 2004 Aug; 96(15):1171-80. PubMed ID: 15292389
[TBL] [Abstract][Full Text] [Related]
46. [Preparation and physicochemical properties of vinorelbine liposomes].
Li XT; Cheng L; Jia TZ
Zhong Yao Cai; 2011 Jan; 34(1):119-22. PubMed ID: 21818978
[TBL] [Abstract][Full Text] [Related]
47. Development of a new topical system: drug-in-cyclodextrin-in-deformable liposome.
Gillet A; Grammenos A; Compère P; Evrard B; Piel G
Int J Pharm; 2009 Oct; 380(1-2):174-80. PubMed ID: 19576972
[TBL] [Abstract][Full Text] [Related]
48. Vascular targeting of doxorubicin using cationic liposomes.
Wu J; Lee A; Lu Y; Lee RJ
Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
[TBL] [Abstract][Full Text] [Related]
49. Ether lipids enhance the cytotoxic effect of teniposide and paclitaxel in liposomes against leukaemic cells in culture.
Lundberg BB
Anticancer Drug Des; 1997 Sep; 12(6):503-13. PubMed ID: 9311558
[TBL] [Abstract][Full Text] [Related]
50. Improved pharmacokinetics and efficacy of a highly stable nanoliposomal vinorelbine.
Drummond DC; Noble CO; Guo Z; Hayes ME; Park JW; Ou CJ; Tseng YL; Hong K; Kirpotin DB
J Pharmacol Exp Ther; 2009 Jan; 328(1):321-30. PubMed ID: 18948499
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of tetraether lipid-based liposomal carriers for encapsulation and retention of nucleoside-based drugs.
Paolucci V; Leriche G; Koyanagi T; Yang J
Bioorg Med Chem Lett; 2017 Sep; 27(18):4319-4322. PubMed ID: 28838688
[TBL] [Abstract][Full Text] [Related]
52. Characterization of highly stable liposomal and immunoliposomal formulations of vincristine and vinblastine.
Noble CO; Guo Z; Hayes ME; Marks JD; Park JW; Benz CC; Kirpotin DB; Drummond DC
Cancer Chemother Pharmacol; 2009 Sep; 64(4):741-51. PubMed ID: 19184019
[TBL] [Abstract][Full Text] [Related]
53. Encapsulation of drugs into large unilamellar liposomes prepared by an extemporaneous method.
Liautard J; Philippot JR; Liautard JP
J Microencapsul; 1991; 8(3):381-9. PubMed ID: 1941445
[TBL] [Abstract][Full Text] [Related]
54. [Synthesis, biological activity and encapsulation of new adrenergic beta-amino alcohols in phospholipid liposomes].
Imzil L; Elamrani K; Charaf A; Bouzoubaa M; Leclerc G
J Pharm Belg; 1993; 48(5):335-40. PubMed ID: 7907141
[TBL] [Abstract][Full Text] [Related]
55. [Preparation and anti-breast cancer activity of (-)-antofine carried with liposomes].
Wu DM; Chen Y; Wu L
Zhong Yao Cai; 2013 Sep; 36(9):1511-4. PubMed ID: 24620699
[TBL] [Abstract][Full Text] [Related]
56. Effervescent granule based proliposomes of ibuprofen.
Katare OP; Vyas SP; Dixit VK
J Microencapsul; 1990; 7(4):455-62. PubMed ID: 2266470
[TBL] [Abstract][Full Text] [Related]
57. The influence of liposomal formulation on the incorporation and retention of PNA oligomers.
Ringhieri P; Avitabile C; Saviano M; Morelli G; Romanelli A; Accardo A
Colloids Surf B Biointerfaces; 2016 Sep; 145():462-469. PubMed ID: 27236097
[TBL] [Abstract][Full Text] [Related]
58. Recent Patents, Formulation Techniques, Classification and Characterization of Liposomes.
Sheoran R; Khokra SL; Chawla V; Dureja H
Recent Pat Nanotechnol; 2019; 13(1):17-27. PubMed ID: 30479223
[TBL] [Abstract][Full Text] [Related]
59. Sulfosalicylate mediates improved vinorelbine loading into LUVs and antineoplastic effects.
Li C; Cui J; Wang C; Cao J; Zhang L; Li Y; Liang M; Xiu X; Li Y; Wei N; Deng C
J Liposome Res; 2012 Mar; 22(1):42-54. PubMed ID: 21696260
[TBL] [Abstract][Full Text] [Related]
60. Characterization of drug encapsulation and retention in archaea-inspired tetraether liposomes.
Leriche G; Cifelli JL; Sibucao KC; Patterson JP; Koyanagi T; Gianneschi NC; Yang J
Org Biomol Chem; 2017 Mar; 15(10):2157-2162. PubMed ID: 28221378
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
